These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Growth hormone (GH) secretion and pituitary size in children with short stature. Efficacy of GH therapy in GH-deficient children, depending on the pituitary size. Hilczer M, Szalecki M, Smyczynska J, Stawerska R, Kaniewska D, Lewinski A. Neuro Endocrinol Lett; 2005 Oct; 26(5):447-52. PubMed ID: 16264418 [Abstract] [Full Text] [Related]
3. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature. Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board. Horm Res; 2007 Oct; 68(2):53-62. PubMed ID: 17228181 [Abstract] [Full Text] [Related]
4. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement]. Korpal-Szczyrska M, Dorant B, Kamińska H, Birkholz D, Niedźwiecki M. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Oct; 12(1):31-4. PubMed ID: 16704859 [Abstract] [Full Text] [Related]
5. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial. Arends NJ, Boonstra VH, Mulder PG, Odink RJ, Stokvis-Brantsma WH, Rongen-Westerlaken C, Mulder JC, Delemarre-Van de Waal H, Reeser HM, Jansen M, Waelkens JJ, Hokken-Koelega AC. Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922 [Abstract] [Full Text] [Related]
6. Role of magnetic resonance imaging in the diagnosis and prognosis of growth hormone deficiency. Bozzola M, Adamsbaum C, Biscaldi I, Zecca M, Cisternino M, Genovese E, Richard I, Kalifa G, Chaussain JL. Clin Endocrinol (Oxf); 1996 Jul; 45(1):21-6. PubMed ID: 8796134 [Abstract] [Full Text] [Related]
8. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency. Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M. J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020 [Abstract] [Full Text] [Related]
12. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, Price DA, KIGS International Board. Clin Endocrinol (Oxf); 2006 Aug; 65(2):178-85. PubMed ID: 16886957 [Abstract] [Full Text] [Related]
13. Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings. Coutant R, Rouleau S, Despert F, Magontier N, Loisel D, Limal JM. J Clin Endocrinol Metab; 2001 Oct; 86(10):4649-54. PubMed ID: 11600520 [Abstract] [Full Text] [Related]
14. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS. Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO. J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724 [Abstract] [Full Text] [Related]
16. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study. Moore WV, Dana K, Frane J, Lippe B. Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719 [Abstract] [Full Text] [Related]
18. The response to treatment with pituitary growth hormone: the New Zealand experience. Livesey JH, Cuneo RC, Donald RA, Harris RG, Ibberston HK, Costello JM, Holdaway IM, Gluckman PD, Fraser TR, Chapman GE. N Z Med J; 1989 Aug 09; 102(873):399-402. PubMed ID: 2761875 [Abstract] [Full Text] [Related]
19. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy. Carvalho LR, de Faria ME, Osorio MG, Estefan V, Jorge AA, Arnhold IJ, Mendonca BB. Clin Endocrinol (Oxf); 2003 Dec 09; 59(6):788-92. PubMed ID: 14974923 [Abstract] [Full Text] [Related]